WeVote
Log In

Bill

Bill

HB 2136

Health, Dept. of - As introduced, directs the department to submit a report of each medication approved by the federal food and drug administration (FDA) for the purpose of women's health, including a synopsis of each medication, to the speaker of the senate and the speaker of the house of representatives on or before January 1, 2027. - Amends TCA Title 39; Title 53; Title 63 and Title 68.

114th Regular Session (2025-2026) Introduced by Bryan Terry

Tennessee must report all FDA-approved women's health medications to legislature by January 2027, potentially laying groundwork for future policy changes.

Am. withdrawn. (Amendment 1 - HA0935)
#dept.of #health
0
WeVote Research Nonpartisan
Bill Summary · HB 2136

Legislative bill overview

HB 2136 requires Tennessee's Department of Health to compile a comprehensive report of all FDA-approved medications for women's health and submit it to legislative leadership by January 1, 2027. The bill modifies state health code sections across multiple titles of Tennessee Code Annotated, though the specific amendments are not detailed in the bill summary provided.

Why is this important

This bill creates a legislative inventory of women's health medications, which could inform future policy discussions, regulatory decisions, or legislative action on women's healthcare access and drug availability in Tennessee. The January 2027 deadline suggests potential follow-up legislation or policy initiatives may depend on this information.

Potential points of contention

  • Scope ambiguity: "Women's health" is not precisely defined, leaving uncertainty about which medications qualify (contraceptives, hormone therapies, pregnancy-related drugs, gynecological treatments, etc.)
  • Resource implications: The report requires Department of Health staff time and resources to research and compile all FDA-approved medications across multiple categories, with unclear funding appropriations
  • Intended use unclear: The bill doesn't specify what lawmakers plan to do with this report, raising questions about whether this is preparatory work for restrictive legislation or regulatory review

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.